Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1991;11:645-652

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by James, R. W.
Right arrow Articles by Hochstrasser, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by James, R. W.
Right arrow Articles by Hochstrasser, D.

Arteriosclerosis and Thrombosis, Vol 11, 645-652, Copyright © 1991 by American Heart Association


ARTICLES

Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement- mediated cytolysis

RW James, AC Hochstrasser, I Borghini, B Martin, D Pometta and D Hochstrasser
Department of Medicine, University Hospital, Geneva, Switzerland.

Two peptides, NA1 and NA2, which we previously suggested to be associated with high density lipoproteins (HDLs), have been purified. Polyclonal antibodies against each peptide and a monoclonal antibody against NA2 have been used to further characterize them and their association with HDL. Immunoblotting studies revealed that the peptides form a complex of molecular mass of approximately 80 kd. Agarose gel filtration showed coelution of NA1/NA2 and apolipoprotein (apo) A-I, the structural protein of HDL. This was confirmed by fast protein liquid chromatography, which further indicated that up to 60% of NA1/NA2 was located within the lower density range of the HDL spectrum. Complementary studies with anti-apo A-I immunoaffinity columns provided evidence that at least 40% of NA1/NA2 was associated with HDL, an association easily disrupted by ultracentrifugal manipulation. Finally, partial amino acid sequences showed virtually complete homology with a recently identified protein, SP-40,40, or cytolysis inhibitor. The protein is suggested to have a powerful inhibitory effect on complement- mediated cell lysis. Our results could thus furnish an explanation for the previously observed modulating influence of HDL on complement activity.


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Thomas-Tikhonenko, I. Viard-Leveugle, M. Dews, P. Wehrli, C. Sevignani, D. Yu, S. Ricci, W. el-Deiry, B. Aronow, G. Kaya, et al.
Myc-Transformed Epithelial Cells Down-Regulate Clusterin, Which Inhibits Their Growth in Vitro and Carcinogenesis in Vivo
Cancer Res., May 1, 2004; 64(9): 3126 - 3136.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. CANDIANO, L. MUSANTE, M. CARRARO, L. FACCINI, L. CAMPANACCI, C. ZENNARO, M. ARTERO, F. GINEVRI, F. PERFUMO, R. GUSMANO, et al.
Apolipoproteins Prevent Glomerular Albumin Permeability Induced In Vitro by Serum from Patients with Focal Segmental Glomerulosclerosis
J. Am. Soc. Nephrol., January 1, 2001; 12(1): 143 - 150.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
T. M. Forte, M. N. Oda, L. Knoff, B. Frei, J. Suh, J. A. K. Harmony, W. D. Stuart, E. M. Rubin, and D. S. Ng
Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration
J. Lipid Res., July 1, 1999; 40(7): 1276 - 1283.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Z. Kounnas, E. B. Loukinova, S. Stefansson, J. A. K. Harmony, B. H. Brewer, D. K. Strickland, and W. S. Argraves
Identification of Glycoprotein 330 as an Endocytic Receptor for Apolipoprotein J/Clusterin
J. Biol. Chem., June 2, 1995; 270(22): 13070 - 13075.
[Abstract] [Full Text] [PDF]